Serotonergic modulation as a pharmacological modality in the treatment of Dravet syndrome

Brain. 2017 Jun 1;140(6):e35. doi: 10.1093/brain/awx090.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Benzimidazoles
  • Epilepsies, Myoclonic*
  • Humans
  • Seizures
  • Serotonin*

Substances

  • Benzimidazoles
  • Serotonin
  • clemizole